TWIN SISTERS AND A RARE DIAGNOSIS: THE STORY OF ELIS AND ELOÁ

In May 2021, twin sisters Elis and Eloá Lima Carneiro were born in Boa Vista, Brazil. During infancy, their family noticed troubling symptoms: extreme difficulty gaining weight, hair loss, and unusual skin changes. By late 2022, doctors confirmed a diagnosis of Hutchinson-Gilford Progeria Syndrome (HGPS)—an extraordinarily rare genetic disorder. Their case drew immediate international attention from researchers, as they were recognized as the only known twins diagnosed with this condition.

HGPS is often described as accelerated aging, caused by a mutation in the LMNA gene that produces an abnormal protein called progerin. While cognitive development remains unaffected, the disorder severely impacts physical growth, skin elasticity, joint health, and most critically, the cardiovascular system. Because most progeria cases stem from spontaneous mutations, studying two identical twins with the condition offers scientists a unique opportunity to understand genetic progression and early development.

Despite the absence of a complete cure, medical advances like lonafarnib (Zokinvy)—approved in 2020—help mitigate mortality risks alongside continuous cardiovascular, nutritional, and physical therapies. By 2024, the sisters celebrated their third birthday while continuing treatment.

Beyond the complex medical terminology, Elis and Eloá are simply two young sisters growing up together with unique personalities. Their story highlights both the clinical complexities of rare diseases and a family’s enduring dedication to providing their children with comfort, care, and a fulfilling childhood.